Cargando…
Amplicon deep sequencing improves Plasmodium falciparum genotyping in clinical trials of antimalarial drugs
Clinical trials monitoring malaria drug resistance require genotyping of recurrent Plasmodium falciparum parasites to distinguish between treatment failure and new infection occurring during the trial follow up period. Because trial participants usually harbour multi-clonal P. falciparum infections,...
Autores principales: | Gruenberg, Maria, Lerch, Anita, Beck, Hans-Peter, Felger, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883076/ https://www.ncbi.nlm.nih.gov/pubmed/31780741 http://dx.doi.org/10.1038/s41598-019-54203-0 |
Ejemplares similares
-
Should Deep-Sequenced Amplicons Become the New Gold Standard for Analyzing Malaria Drug Clinical Trials?
por: Jones, Sam, et al.
Publicado: (2021) -
Extrachromosomal DNA amplicons in antimalarial‐resistant Plasmodium falciparum
por: McDaniels, Jennifer M., et al.
Publicado: (2020) -
Development of amplicon deep sequencing markers and data analysis pipeline for genotyping multi-clonal malaria infections
por: Lerch, Anita, et al.
Publicado: (2017) -
Molecular epidemiology of Plasmodium falciparum by multiplexed amplicon deep sequencing in Senegal
por: Ndiaye, Tolla, et al.
Publicado: (2020) -
Detection of low-density Plasmodium falciparum infections using amplicon deep sequencing
por: Early, Angela M., et al.
Publicado: (2019)